Photodynamic therapy with a new photosensitizing agent

Aline Helena Araujo Machado1, Fernanda Maria Prado Braga, Cristina Pacheco Soares

  • 1Cell and Tissue Biology Laboratory, Institute for Research and Development (IP&D), Universidade do Vale do Paraíba (UNIVAP), São José dos Campos, São Paulo, Brazil.

Summary

Octal-bromide zinc phthalocyanine (ZnPcBr(8)) effectively induces cancer cell death via photodynamic therapy (PDT). This study reveals ZnPcBr(8) triggers apoptosis in L929 cells, demonstrating its potential as a photosensitizing agent.

Related Concept Videos